Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$119.98 - $132.61 $2,639 - $2,917
-22 Reduced 1.73%
1,252 $165,000
Q4 2023

Mar 18, 2024

SELL
$102.72 - $121.7 $64,713 - $76,671
-630 Reduced 33.09%
1,274 $155,000
Q3 2023

Dec 18, 2023

BUY
$110.76 - $143.18 $4,762 - $6,156
43 Added 2.31%
1,904 $213,000
Q2 2023

Aug 07, 2023

SELL
$126.43 - $145.6 $18,964 - $21,840
-150 Reduced 7.46%
1,861 $270,000
Q1 2023

May 15, 2023

SELL
$121.91 - $130.94 $2,803 - $3,011
-23 Reduced 1.13%
2,011 $259,000
Q3 2022

Nov 16, 2022

SELL
$101.65 - $119.27 $12,604 - $14,789
-124 Reduced 5.75%
2,034 $213,000
Q2 2022

Aug 16, 2022

BUY
$102.23 - $133.85 $21,979 - $28,777
215 Added 11.07%
2,158 $227,000
Q4 2020

Feb 16, 2021

BUY
$128.25 - $151.41 $249,189 - $294,189
1,943 New
1,943 $299,000

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.1B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Core First Bank & Trust Portfolio

Follow Core First Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core First Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Core First Bank & Trust with notifications on news.